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ABSTRACT
Objective: The treatment of symptomatic carotid-cavernous fistulas [CCF] has been historically treated in the developed world through the endovascular route. We report our first case of using a covered stent in a patient with spontaneous CCF. Method: Single patient with spontaneous indirect high flow CCF treated with a covered stent. We present
retrospective analysis of technical success, initial and 6-month follow-up angiography and clinical outcome. Result:
The stent was successfully navigated and deployed covering the CCF orifice. Immediate post stent deployment angiography showed marked reduction in flow and complete occlusion at 6-months. Clinically, patient showed near-complete
recovery at 6 months. Conclusion: With proper neuroendovascular training and experience, use of a covered stent is
cost effective and feasible for the treatment of CCFs in under developed countries.
Key Words: Carotid-cavernous fistula, spontaneous, endovascular treatment, Covered stents.
INTRODUCTION

episcleral vessel venous congestion, visual blurring and
exophthalmos. His detailed ophthalmologic examination
had earlier shown elevated intraocular pressure. Prior to
the procedure, patient had received coated Aspirin
[75mg/d] and Clopidogrel [75mg/d] for 5 consecutive
days. The procedure was performed under general anesthesia. After a 6-F guide catheter was positioned in the
distal right carotid artery, the initial diagnostic angiography showed an indirect right CCF (12). [Barrow’s Classification – Type D]. The arterial supply to the CCF was from
the capsular branches of the right cavernous ICA [Fig 1]
and a few tiny feeders from the right External Carotid
Artery [ECA] [Fig 2]. Its venous drainage was into the
cavernous sinus and superior ophthalmic vein. Based on
the angiographic findings a vessel reconstructive
approach using a covered stent was planned. Abbott
Vascular Jostent Grafmaster is a low profile stent system
constructed using a sandwich technique with an ultrathin expandable Polytetrafluoroethylene (PTFE) placed
between the two stainless steel Jostent stents. The
patient was systemically heparinized and serial ACTs were
obtained at regular intervals. A 0.014 mm BMW microwire was navigated into a distal branch of right middle
cerebral artery. Under road map guidance, a Jostent
Graftmaster 3.5 mm x 16mm was advanced and the
orifice of the fistula was bridged. Immediate post stent
angiography confirmed accurate stent placement but
stent endoleak was noticed. The stent was post dilated to
stop or further reduce the endoleak using UltraSoft

Abnormal communication between the carotid arterial
system and cavernous sinus results in Carotid Cavernous Fistula [CCF]. Iatrogenic damage [trans-sphenoidal
surgery, glycerol rhizotomy etc] as well as blunt and
penetrating head trauma may lead to direct CCF (1-2).
CCFs not associated with history of trauma are regarded
as spontaneous. Conditions that weaken the Internal
Carotid Artery [ICA] wall can lead to spontaneous CCF.
Predisposing conditions include rupture of carotid
cavernous aneurysm, atherosclerosis, connective tissue
disorders like Ehlers-Danlos syndrome, fibromuscular
dysplasia and pseudoxanthoma elasticum (3-7). Treatment modalities include conservative approach i.e.
manual compression therapy, surgical management
[carotid ligation], stereotactic radiosurgery and endovascular management encompassing either or combination
of transarterial and transvenous approaches. Endovascular transarterial technique employing reconstructive
approach with a covered stent has shown impressive
results. This technique reduces the procedure time and
cost by covering the fistula ostium (8-11). The purpose of
our study was to present our preliminary experience and
feasibility of using a covered stent for CCF treatment.
TECHNIQUE
A 35-year-old man sought medical attention with a few
weeks history of gradually progressive conjunctiva and
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complete occlusion of the fistula without recanalization
and parent artery patency without in-stent stenosis.
Indirect CCFs are also called dural fistulas and harbor
low flow rate. Such fistulas can be approached via transvenous and transarterial routes. In the transvenous
approach the abnormal cavernous sinus is superselectively catheterized to occlude the fistula without compromising the venous drainage (1,3, 13). The technical
challenge to the transvenous approach includes venous
perforation. Depending on venous route chosen can be
fatal if the brainstem is involved. The transarterial
technique involves catherization of the ECA arterial feeders followed by satisfactory occlusion using liquid
embolic agents [n-BCA, EVOH, Onyx]. Other therapeutic
modalities include detachable balloon [DB] occlusion of
the CCF (14, 17). Residual or recurrent CCF and pseudoaneurysm formation is major complication associated
with DBs. Coil embolization is another alternative
approach to occlude these fistulas. It was entertained in
our case but was not considered feasible because of
high cost and non-availability of surgical expertise to
acquire direct supra orbital access via the superior
ophthalmic vein. Covered stents have been used in a
vast array of cerebrovascular disorders including aneurysms, dissection, pseudoaneurysm and CCFs (8-11,
18-21). The technically important and challenging factor
is the complete closure of the fistula orifice. The drawbacks include CCF recurrence and endoleak that does
not occur if the orifice is completely closed. In our case,
the covered stent could be delivered safely.

5.0x20x153cm angioplasty balloon. Then, Microvention
Headway 17 micro catheter was advanced over BMW
0.014mm microwire and its tip positioned into the right
internal maxillary arterial fistulous feeder branch to the
right CCF. The branch was intentionally sacrificed using
0.5cc of approximately 33% diluted n-butyl cyanoacrylate [n-BCA] glue. Post procedure angiography demonstrated complete obliteration of the right ECA branch
arterial feeders to the right CCF and mild stent endoleak
with angioghraphically-reduced flow in the Right CCF [Fig
3]. The patient recovered from anesthesia uneventfully
and reported improvement with his vision and reduction
in exophthalmos. He was instructed to continue dual
antiplatelet therapy for 6 months to avoid thrombosis
and in-stent stenosis. Patient’s six-month follow-up
angiography showed complete obliteration of the right
CCF [Fig 4]. The clinical follow-up assessment was
graded as near full recovery with improving residual mild
chemosis and exophthalmos.

Fig 1: Selective Right ICA angiography [Oblique view]
showing indirect Right CCF.
DISCUSSION
The first therapeutic modality for CCFs currently is the
Endovascular embolization because it is associated with
high occlusion and low complication rates. The endovascular therapeutic modalities for CCFs involve the use of
different embolic materials including detachable
balloons, silk, coils, n-butyl cyanoacrylate (n-BCA),
covered stents, and Onyx. In our experience, we found
the use of a covered stent as a feasible therapeutic
option for indirect CCF. The final angiogram showed
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Fig 2: Selective Right ECA Angiography [Anteroposterior
view] showing an arterial feeder to the Right CCF.
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As such, stents are not readily available in Pakistan.
Hence, we had to rely on the slightly smaller diameter
stent followed by post deployment larger diameter
balloon angioplasty. Post angioplasty, the degree of
endoleak improved. Even though the patient symptoms
were improving but he was brought back for a second
attempt to deliver a larger diameter stent at four months
but the stent navigation through the previously deployed
stent was technically challenging and the procedure was
aborted.

Fig 4: Six-Month follow-up angiography showing complete
obliteration of the right CCF.
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